U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
autologous CD4+/CD8+ enriched T lymphocytes derived from leukapheresis material, transduced with a self-inactivating, non-replicating lentiviral vector encoding a CD19 targeting chimeric antigen receptor (CAR) comprising a CD8 alpha (CD8?) signal peptide
Preferred Name English
Mivocabtagene Autoleucel
INN  
Official Name English
mivocabtagene autoleucel [INN]
Common Name English
Code System Code Type Description
FDA UNII
QTE27WBS5A
Created by admin on Wed Apr 02 17:49:40 GMT 2025 , Edited by admin on Wed Apr 02 17:49:40 GMT 2025
PRIMARY
INN
13488
Created by admin on Wed Apr 02 17:49:40 GMT 2025 , Edited by admin on Wed Apr 02 17:49:40 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966